Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoraDoc vs Fifty 410

By GLP-1 ScorecardUpdated

CoraDocFactor scores not reassessed.
Site position #49

Higher score

Fifty 410Factor scores not reassessed.
Site position #207

Lower score

Score comparison

CoraDoc has the higher recorded score — 76.8/100 to 66.3/100.

CoraDoc grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. CoraDoc advertises one upfront payment for a selected GLP-1 program. Its sales page and written refund policy give different answers about what you may get back.

Before you choose

Before comparing the headline prices, the CoraDoc review and the Fifty 410 review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, CoraDoc vs Harbor and CoreAge Rx vs Fifty 410 compare each of them with another graded program, and the list of alternatives to CoraDoc ranks the programs closest to CoraDoc on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Collective review covers one graded close to these two, at 71.6/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueCoraDoc +10
96
86
Dose & formulationEven
72
72
Clinical oversightCoraDoc +24
79
55
Labs & monitoringEven
53
53
FulfillmentCoraDoc +5
76
71
Contract termsCoraDoc +32
69
37
CoraDoc · top barFifty 410 · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricCoraDocFifty 410
WeighScore76.8/10066.3/100
GradeCC
Site position#49#207
Semaglutide$924 upfront (12-month promotion, compounded)$199 for 4 weeks (compounded)
Tirzepatide$1,524 upfront (12-month promotion, compounded)$199 for 4 weeks or $299 for 8 weeks where available (compounded)
CoverageCoverage not publishedFour-week programs advertised in all 50 states; eight-week offer excludes nine states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
CoraDoc

Site position #49 · C

Factor scores not reassessed.

Strengths

  • The 12-month promotion publishes the one-time payment for each medication
  • The campaign lists clinician visits, medication, dose increases, shipping and supplies as included
  • The weight-loss campaign advertises no automatic renewal for the annual offer

What to consider

  • The lowest advertised monthly equivalents require paying for 12 months at once
  • The refund policy describes a possible $100 clinical fee after medical ineligibility, despite the sales-page full-refund promise
  • The pages checked did not name the dispensing pharmacy for an individual order
Fifty 410

Site position #207 · C

Factor scores not reassessed.

FDAWarning letter issued to Aspen Aesthetics dba Fifty 410 in February 2026. See the FDA warning-letter database.

Strengths

  • Publishes separate four- and eight-week tirzepatide totals
  • Lists consultation and shipping in the program price

What to consider

  • The eight-week offer excludes nine states
  • The refund policy generally excludes cancellation refunds once compounding starts
  • FDA issued Aspen Aesthetics dba Fifty 410 a warning letter in February 2026; the letter is public in FDA's warning-letter database

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard